Aug 2026· Stem Cell Reviews and Reports· 2 citations· 201 references
Medicine
TL;DR
This review integrates current evidence within an NVU-centered systems biology framework and aligns therapeutic strategies with the disease hierarchy, distinguishing established clinical treatments from preclinical and emerging interventions.
Studies have identified the involvement of microvascular injury, neurovascular unit (NVU) dysfunction, and retinal hemodynamic abnormalities in diabetic retinal diseases, including diabetic retinopathy and diabetic macular edema (DME). Although chronic hyperglycemia is the central driver of retinal damage, mounting evi...
T. Kida, J. Flammer· Experimental Eye Research· 0 citations
AIMS
Diabetic retinopathy (DR) is a sight-threatening consequence of diabetes. DR disrupts cell-to-cell communication in the retinal neurovascular unit (NVU), impairing blood flow which leads to vascular complications. Here, we propose an integrated framework of DR pathogenesis in which impaired clearance mechanisms an...
Karis Little, Judith Lechner, G. De Rossi et al.· Diabetic Medicine· 0 citations
Diabetic retinopathy (DR) has traditionally been regarded as a microvascular complication, but increasing evidence supports its classification as a neurovascular disease. The retinal neurovascular unit (NVU), comprising neurons, glial, and vascular, elements, is crucial for retinal homeostasis and is disrupted early in...
S. Fragiotta, C. Ciancimino, G. Scuderi· Archivos de la Sociedad Espa...· 0 citations
Diabetic retinopathy (DR) has long been regarded as an isolated retinal microvascular disease. Histopathological, molecular, imaging, and multi-omics evidence now supports disruption of retinal neurovascular unit (NVU) homeostasis as a central mechanism of DR, in which neuronal degeneration, reactive gliosis, and m...
Hui Liu, Jing Wu, Heng Jiang et al.· Frontiers in Medicine· 0 citations
Current evidence supporting ferroptosis-related vulnerability in retinal neurodegenerative diseases is synthesized and emerging enabling strategies are evaluated, including nanocarrier-based delivery, long-acting gene modulation, and biomarker frameworks integrating ocular fluids, imaging, multi-omics, and artificial i...
Guang-Guang Wu, Su-Yu Wang, Zi-Yi Chen et al.· Frontiers in Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.